Our services

H-Research Asia provides decision-focused healthcare research for life science teams across Asia-Pacific. Clients work with us to answer clear business questions within defined markets, covering market access, launch preparation, and post-launch optimisation.

Access decisions in Asia depend on how payers assess value, what evidence they expect, and where affordability limits sit. We clarify these factors so teams understand what is achievable in each market and where the main risks lie.

This work is used to support decisions such as:

  • Setting realistic pricing and affordability levels

  • Local evidence needs for value discussions and reimbursement decisions

  • Mapping reimbursement and formulary pathways in public and private systems

  • Identifying payer concerns and access barriers

  • Designing or refining patient access programmes

  • The output informs access strategy, evidence planning, and payer engagement within target countries.

Scroll to Top